It's free and takes less than a minute to check and compare. You can call BT on 0330 1234 150 for whatever reason you need to get in touch. Broadband and landline customers should press 1, TV and ...

TTVR plus optimal medical therapy yields greater improvement in disease-specific and general health status than OMT alone. HealthDay News — For patients with symptomatic and severe or greater ...

For patients with symptomatic and severe tricuspid regurgitation (TR), tricuspid transcatheter edge-to-edge repair (T-TEER) yields significant improvements in primary end points, according to a ...

For patients with symptomatic and severe or greater tricuspid regurgitation (TR), transcatheter tricuspid valve replacement (TTVR) plus optimal medical therapy (OMT) yields substantial improvement ...

Learn More. For me, the rising BT (LSE:BT.A) share price represents something of a missed opportunity. I had watched it closely around £1, but didn’t make the investment I intended. The stock ...

Telecoms and broadband giant BT Group has reportedly begun the process of making their ‘Global’ division available for sale, either in whole or in pieces. The international arm of the business, which ...

TRISCEND II is a randomized controlled pivotal trial designed to study the groundbreaking EVOQUE transcatheter tricuspid valve replacement (TTVR) system with optimal medical therapy (OMT) compared to ...

Severe tricuspid regurgitation is associated with disabling symptoms and an increased risk of death. Data regarding outcomes after percutaneous transcatheter tricuspid-valve replacement are needed.

Two devices approved by the U.S. Food and Drug Administration (FDA) this year for tricuspid regurgitation (TR) are safe, effective and improve quality of life (QOL) at one year, according to studies ...

Optimal Device Selection Based on Anatomy: Why do We Need More Than One Device? (Case-based Examples of Poor Fits) Receive the the latest news, research, and presentations from major meetings right to ...

A broadband business set up to challenge BT is on the brink of collapse after its key investor said it was pulling the plug on funding. Spring Fibre, which raised more than £150m to build a full ...

DUBLIN--(BUSINESS WIRE)--CroíValve, a pioneering medical device company focused on the development of a novel transcatheter device for the treatment of severe+ tricuspid regurgitation (TR ...